Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9421)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 15, 2020 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chakrabarti S, Peterson CY, Sriram D, Mahipal A. Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions. World J Gastrointest Oncol 2020; 12(8): 808-832 [PMID: 32879661 DOI: 10.4251/wjgo.v12.i8.808] |
|---|---|
| URL: | https://www.wjgnet.com/2219-2832/full/v12/i8/808.htm |
| Number | Citing Articles |
| 1 |
Paul Wong, Gregory P. Victorino, Emily Miraflor, Adnan Alseidi, Ajay V. Maker, Lucas W. Thornblade. Impact of safety‐net hospital burden on achievement of textbook oncologic outcomes following resection in for stage I–IV colorectal cancer. Journal of Surgical Oncology 2024; 129(2): 284 doi: 10.1002/jso.27474
|
| 2 |
Sakti Chakrabarti, Amit Mahipal. Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer. Pharmacogenomics 2023; 24(1): 1 doi: 10.2217/pgs-2022-0170
|
| 3 |
Yajing Sun, Qingshan Yang, Xue Xia, Xiaozhe Li, Weimin Ruan, Meng Zheng, Yan Zou, Bingyang Shi. Polymeric Nanoparticles for Mitochondria Targeting Mediated Robust Cancer Therapy. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.755727
|
| 4 |
Mia Shepherdson, Shalem Leemaqz, Gurmeet Singh, Courtney Ryder, Shahid Ullah, Karla Canuto, Joanne P. Young, Timothy J. Price, Ross A. McKinnon, Stephen J. Pandol, Claire T. Roberts, Savio George Barreto. Young-Onset Gastrointestinal Adenocarcinoma Incidence and Survival Trends in the Northern Territory, Australia, with Emphasis on Indigenous Peoples. Cancers 2022; 14(12): 2870 doi: 10.3390/cancers14122870
|
| 5 |
Midhun Malla, Jonathan M Loree, Pashtoon Murtaza Kasi, Aparna Raj Parikh. Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices. Journal of Clinical Oncology 2022; 40(24): 2846 doi: 10.1200/JCO.21.02615
|
| 6 |
Anna Radajewska, Helena Moreira, Dorota Bęben, Oliwia Siwiela, Anna Szyjka, Katarzyna Gębczak, Paulina Nowak, Jakub Frąszczak, Fathi Emhemmed, Christian D. Muller, Ewa Barg. Combination of Irinotecan and Melatonin with the Natural Compounds Wogonin and Celastrol for Colon Cancer Treatment. International Journal of Molecular Sciences 2023; 24(11): 9544 doi: 10.3390/ijms24119544
|
| 7 |
Kruti B Vora, Sameer Tolay, Aparna R Parikh, Sakti Chakrabarti. Organ Preservation in Colon Cancer: An Illustrative Case Report. Cureus 2022; doi: 10.7759/cureus.25351
|
| 8 |
Longfei Dai, Xu Wang, Tao Bai, Jianjun Liu, Bo Chen, Ting Li, Wenqi Yang. Identification of a novel cellular senescence-related signature for the prediction of prognosis and immunotherapy response in colon cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.961554
|
| 9 |
Xi-Yuan Xu, Run-Zhi Zhao, Guo-Hua Zhang. Effect of surgical starting time and season on prognosis in octogenarians with colorectal cancer: a retrospective study. Future Oncology 2022; 18(40): 4493 doi: 10.2217/fon-2022-1292
|
| 10 |
Yewei Wang, Zeljka Popovic, Georgia Charkoftaki, Rolando Garcia-Milian, TuKiet T. Lam, David C. Thompson, Ying Chen, Vasilis Vasiliou. Multi-omics profiling reveals cellular pathways and functions regulated by ALDH1B1 in colon cancer cells. Chemico-Biological Interactions 2023; 384: 110714 doi: 10.1016/j.cbi.2023.110714
|
| 11 |
Lionel Larribère, Uwe M. Martens. Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors. Cancers 2021; 13(22): 5698 doi: 10.3390/cancers13225698
|
| 12 |
Mirna El Dirani, Julius M Nagaratnam, Thebuoshon Amalathasan, Chandni Patel, Mutah Kholoki, Samer Kholoki. Findings of Epstein-Barr Virus Large B-Cell Lymphoma in a Patient With a History of Rectal Adenocarcinoma: A Case Report. Cureus 2023; doi: 10.7759/cureus.40680
|
| 13 |
Aparna R. Parikh, Emily E. Van Seventer, Giulia Siravegna, Anna V. Hartwig, Ariel Jaimovich, Yupeng He, Katie Kanter, Madeleine G. Fish, Kathryn D. Fosbenner, Benchun Miao, Susannah Phillips, John H. Carmichael, Nihaarika Sharma, Joy Jarnagin, Islam Baiev, Yojan S. Shah, Isobel J. Fetter, Heather A. Shahzade, Jill N. Allen, Lawrence S. Blaszkowsky, Jeffrey W. Clark, Jon S. Dubois, Joseph W. Franses, Bruce J. Giantonio, Lipika Goyal, Samuel J. Klempner, Ryan D. Nipp, Eric J. Roeland, David P. Ryan, Colin D. Weekes, Jennifer Y. Wo, Theodore S. Hong, Liliana Bordeianou, Cristina R. Ferrone, Motaz Qadan, Hiroko Kunitake, David Berger, Rocco Ricciardi, James C. Cusack, Victoria M. Raymond, AmirAli Talasaz, Genevieve M. Boland, Ryan B. Corcoran. Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer. Clinical Cancer Research 2021; 27(20): 5586 doi: 10.1158/1078-0432.CCR-21-0410
|
| 14 |
Reham M. M. El-Hazek, Nashwa H. Zaher, Hagar E. S. Emam, Marwa G. El-Gazzar, Amira Khalil. Pyrazole-sulfonamide scaffold featuring dual-tail strategy as apoptosis inducers in colon cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32820-0
|
| 15 |
Sakti Chakrabarti, Anup Kumar Kasi, Aparna R. Parikh, Amit Mahipal. Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC). Cancers 2022; 14(13): 3078 doi: 10.3390/cancers14133078
|
| 16 |
Hua Li, Yan-Xu Hou, Yu Yang, Qing-Qiang He, Tian-Hua Gao, Xiao-Feng Zhao, Zhi-Bin Huo, Shu-Bo Chen, Deng-Xiang Liu. Tetramethylpyrazine inhibits proliferation of colon cancer cells <i>in vitro</i>. World Journal of Clinical Cases 2021; 9(18): 4542-4552 doi: 10.12998/wjcc.v9.i18.4542
|
| 17 |
Christy Kei, Richard Gartrell, Yasser Arafat, Elizabeth Degabriele, Josephine Yeung, Steven Chan, Ian Faragher, Justin M. C. Yeung. Colorectal cancer treatment outcomes during the pandemic: Our experience of COVID‐19 at a tertiary referral center. Asia-Pacific Journal of Clinical Oncology 2024; doi: 10.1111/ajco.14051
|
| 18 |
Maria Pihlmann Kristensen, Ulrik Korsgaard, Signe Timm, Torben Frøstrup Hansen, Inti Zlobec, Henrik Hager, Sanne Kjær-Frifeldt. The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program. Human Pathology 2024; 146: 15 doi: 10.1016/j.humpath.2024.02.010
|
| 19 |
Babak Pakbin, Samaneh Allahyari, Shaghayegh Pishkhan Dibazar, Amir Peymani, Mozhdeh Khajeh Haghverdi, Khadijeh Taherkhani, Maryam Javadi, Razzagh Mahmoudi. Anticancer Properties of Saccharomyces boulardii Metabolite Against Colon Cancer Cells. Probiotics and Antimicrobial Proteins 2024; 16(1): 224 doi: 10.1007/s12602-022-10030-w
|
| 20 |
Zhila Izadi, Maryam Rashidi, Hossein Derakhshankhah, Mozhdeh Dolati, Mohammad Ghanbari Kermanshahi, Hadi Adibi, Hadi Samadian. Curcumin-loaded porous particles functionalized with pH-responsive cell-penetrating peptide for colorectal cancer targeted drug delivery. RSC Advances 2023; 13(49): 34587 doi: 10.1039/D3RA06270H
|
| 21 |
David A. Santos, Liangliang Zhang, Kim-Anh Do, Brian K. Bednarski, Celia Robinson Ledet, Angela Limmer, Heather Gibson, Y. Nancy You. Chemotherapy and Abdominal Wall Closure Technique Increase the Probability of Postoperative Ventral Incisional Hernia in Patients With Colon Cancer. The American Surgeon 2023; 89(1): 98 doi: 10.1177/00031348211011149
|
| 22 |
Chee Cheong, Allan Golder, Paul Horgan, Campbell Roxburgh, Donald Mcmillan. Relationship between pre‑operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery. Oncology Letters 2022; 24(3) doi: 10.3892/ol.2022.13416
|
| 23 |
Daniel Sur, Alecsandra Gorzo, Claudia Burz. Recent Understanding of Colorectal Cancer Treatment. 2022; doi: 10.5772/intechopen.105377
|
| 24 |
Gary Kelloff, Caroline C. Sigman. Circulating Tumor Cells. Current Cancer Research 2023; : 443 doi: 10.1007/978-3-031-22903-9_17
|
| 25 |
Byung Woog Kang, Dong Won Baek, Eunhye Chang, Hye Jin Kim, Su Yeon Park, Jun Seok Park, Gyu Seog Choi, Jin Ho Baek, Jong Gwang Kim. Clinical implication of adjuvant chemotherapy according to mismatch repair status in patients with intermediate-risk stage II colon cancer: a retrospective study. Journal of Yeungnam Medical Science 2022; 39(2): 141 doi: 10.12701/yujm.2021.01571
|
| 26 |
Yuanchang Zhu, Zeyi Zhao, Mya Thandar, Junhao Cheng, Pan Chi, Shenghui Huang. Expression patterns and prognostic value of key regulators associated with m7G RNA modification based on all gene expression in colon adenocarcinoma. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02657-y
|
| 27 |
Xing Wang, Ziyun Qiao, Beatrice Aramini, Dong Lin, Xiaolong Li, Jiang Fan. Potential biomarkers for immunotherapy in non-small-cell lung cancer. Cancer and Metastasis Reviews 2023; 42(3): 661 doi: 10.1007/s10555-022-10074-y
|
| 28 |
Man Xiong, Mingsen Wang, Youhong Yan, Xiaowu Chen, Wanwei Guo, Ming Xu, Shaoyan Guo, Yeyang Wang, Jinghua Pan. MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/8326940
|
| 29 |
Kevin J. Chang, David H. Kim, Tasneem K. Lalani, Viktoriya Paroder, Perry J. Pickhardt, Hiram Shaish, David D. B. Bates. Radiologic T staging of colon cancer: renewed interest for clinical practice. Abdominal Radiology 2023; 48(9): 2874 doi: 10.1007/s00261-023-03904-2
|
| 30 |
Angelika Svetlove, Titus Griebel, Jonas Albers, Lorenzo D’Amico, Philipp Nolte, Giuliana Tromba, Hanibal Bohnenberger, Frauke Alves, Christian Dullin. X-ray phase-contrast 3D virtual histology characterises complex tissue architecture in colorectal cancer. Frontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1283052
|
| 31 |
Abdullah A. Alkahtane, Hamzah A. Alghamdi, Alanoud T. Aljasham, Saad Alkahtani. A possible theranostic approach of chitosan-coated iron oxide nanoparticles against human colorectal carcinoma (HCT-116) cell line. Saudi Journal of Biological Sciences 2022; 29(1): 154 doi: 10.1016/j.sjbs.2021.08.078
|
| 32 |
Elena Elez, Antonio Cubillo, Pilar Garcia Alfonso, Mark R. Middleton, Ian Chau, Baha Alkuzweny, Ann Alcasid, Xiaosong Zhang, Eric Van Cutsem. Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12153-5
|
| 33 |
Early Residual Disease and Recurrence Monitoring of Early-Stage CRC. Clinical OMICs 2021; 8(S1): 9 doi: 10.1089/clinomi.08.S1.05
|
| 34 |
Jessica Debattista, Laura Grech, Christian Scerri, Godfrey Grech. Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies. International Journal of Molecular Sciences 2023; 24(2): 1738 doi: 10.3390/ijms24021738
|
| 35 |
T. Yoshino, G. Argilés, E. Oki, E. Martinelli, H. Taniguchi, D. Arnold, S. Mishima, Y. Li, B.K. Smruti, J.B. Ahn, I. Faud, C.E. Chee, K.-H. Yeh, P.-C. Lin, C. Chua, H.H. Hasbullah, M.A. Lee, A. Sharma, Y. Sun, G. Curigliano, H. Bando, F. Lordick, T. Yamanaka, J. Tabernero, E. Baba, A. Cervantes, A. Ohtsu, S. Peters, C. Ishioka, G. Pentheroudakis. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer. Annals of Oncology 2021; 32(12): 1496 doi: 10.1016/j.annonc.2021.08.1752
|
| 36 |
Min Li, Linxu Wang, Yingjie Wei, Wenyan Wang, Zongliang Liu, Aixia Zuo, Wanhui Liu, Jingwei Tian, Hongbo Wang. Anti-Colorectal Cancer Effects of a Novel Camptothecin Derivative PCC0208037 In Vitro and In Vivo. Pharmaceuticals 2022; 16(1): 53 doi: 10.3390/ph16010053
|
| 37 |
Susanne K. Pedersen, Erin L. Symonds, Amitesh C. Roy, Kathryn J. Cornthwaite, Lawrence C. LaPointe, Graeme P. Young. Detection of methylated BCAT1 and IKZF1 after curative‐intent treatment as a prognostic indicator for colorectal cancer recurrence. Cancer Medicine 2023; 12(2): 1319 doi: 10.1002/cam4.5008
|
| 38 |
Anusha Chidharla, Eliot Rapoport, Kriti Agarwal, Samragnyi Madala, Brenda Linares, Weijing Sun, Sakti Chakrabarti, Anup Kasi. Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 2023; 24(12): 10230 doi: 10.3390/ijms241210230
|
| 39 |
Midhun Malla, Aparna R. Parikh. Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal Cancer. Hematology/Oncology Clinics of North America 2022; 36(3): 583 doi: 10.1016/j.hoc.2022.02.009
|
| 40 |
Jonadab E Olguin, Monica G Mendoza-Rodriguez, C Angel Sanchez-Barrera, Luis I Terrazas. Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?. World Journal of Gastrointestinal Oncology 2023; 15(2): 251-267 doi: 10.4251/wjgo.v15.i2.251
|
| 41 |
Xiaoyuan Fan, Jiakai Zhang, Dewen Lu. CtDNA’s prognostic value in patients with early-stage colorectal cancer after surgery: A meta-analysis and systematic review. Medicine 2023; 102(6): e32939 doi: 10.1097/MD.0000000000032939
|
| 42 |
Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin J. Raftery, Gabriele Pecher. Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer. Cancers 2024; 16(2): 388 doi: 10.3390/cancers16020388
|
| 43 |
Hyun Jin Joo, Jee Ung Seok, Byung Chang Kim, Dong-eun Lee, Bun Kim, Kyung Su Han, Chang Won Hong, Dae Kyung Sohn, Dong Woon Lee, Sung Chan Park, Hee Jin Chang, Jae Hwan Oh. Effects of prior endoscopic resection on recurrence in patients with T1 colorectal cancer who underwent radical surgery. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04448-z
|
| 44 |
Sakti Chakrabarti, Hao Xie, Raul Urrutia, Amit Mahipal. The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review. Cancers 2020; 12(10): 2808 doi: 10.3390/cancers12102808
|
| 45 |
Pablo Azcue, Ignacio Encío, David Guerrero Setas, Javier Suarez Alecha, Arkaitz Galbete, María Mercado, Ruth Vera, Maria Luisa Gomez-Dorronsoro. PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification. Cancers 2021; 13(8): 1943 doi: 10.3390/cancers13081943
|
| 46 |
Samaa Abdullah. Recent Understanding of Colorectal Cancer Treatment. 2022; doi: 10.5772/intechopen.105982
|
| 47 |
Tingting Li, Hang Li, Wenxin Xia, Mengyuan Li, Yang Niu, Xueyan Fu, Alessandro Poggi. Investigation of the Effects of Glabridin on the Proliferation, Apoptosis, and Migration of the Human Colon Cancer Cell Lines SW480 and SW620 and Its Mechanism Based on Reverse Virtual Screening and Proteomics. Oxidative Medicine and Cellular Longevity 2023; 2023: 1 doi: 10.1155/2023/1117431
|
| 48 |
Nasim Eivazi, Reza Mirfakhraie, Ehsan Nazemalhosseini Mojarad, Javad Behroozi, Vahid Reza Yassaee, Mohammad Tahmaseb, Hossein Sadeghi. Association of HOTAIR rs2366152 and rs1899663 polymorphisms with colorectal cancer susceptibility in Iranian population: A case–control study. Journal of Clinical Laboratory Analysis 2023; 37(9-10) doi: 10.1002/jcla.24931
|
| 49 |
Tahseen Bilal Rather, Ishrat Parveiz, Gulzar A Bhat, Gowhar Rashid, Kulsum Akhtar, Rizwanul Haque, Mohammad Shamsul Ola, Mehboob Ali, Rauf A Wani, Ishrat Younas Khan, Syed Besina, Syed Mudassar. Colorectal Cancer (CRC): Investigating the Expression of the Suppressor of Fused (SuFu) Gene and Its Relationship with Several Inflammatory Blood-Based Biomarkers. Biomedicines 2023; 11(2): 540 doi: 10.3390/biomedicines11020540
|
| 50 |
Ariana Znaor, Sultan Eser, Karima Bendahhou, Wael Shelpai, Najla Al Lawati, Amani ELBasmi, Elias Mamo Alemayehu, Mohammed Adnane Tazi, Cankut Yakut, Marion Piñeros. Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population‐based cancer registry study. International Journal of Cancer 2024; doi: 10.1002/ijc.34895
|
| 51 |
Yi Ji, Jialin Gu, Hongqun Zhang, Houxi Xu. Identification and Validation of Key miRNAs for Colon Cancer Based on miRNA-Gene Integration Analysis. International Journal of General Medicine 2023; : 5703 doi: 10.2147/IJGM.S440340
|
| 52 |
Matthew G. Davey, Amira H. Amir, Odhrán K. Ryan, Mark Donnelly, Noel E. Donlon, Mark Regan, Babak Meshkat, Emmeline Nugent, Myles Joyce, Aisling M. Hogan. Evaluating the oncological safety of neoadjuvant chemotherapy in locally advanced colon carcinoma: a systematic review and meta-analysis of randomised clinical trials and propensity-matched studies. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04482-x
|
| 53 |
Nasim Golestannezhad, Adeleh Divsalar, Farideh Badalkhani-Khamseh, Milad Rasouli, Arefeh Seyedarabi, Behafarid Ghalandari, Xianting Ding, Fatemeh Goli, Sander Bekeschus, Ali Akbar Moosavi Movahedi, Mahboube Eslami Moghadam. Oxali-palladium nanoparticle synthesis, characterization, protein binding, and apoptosis induction in colorectal cancer cells. Journal of Materials Science: Materials in Medicine 2024; 35(1) doi: 10.1007/s10856-023-06766-8
|